Alzahrani AS - Search Results

1

Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma.

Zou M, BinHumaid FS, Alzahrani AS, Baitei EY, Al-Mohanna FA, Meyer BF, Shi Y. Zou M, et al. Among authors: alzahrani as. Clin Endocrinol (Oxf). 2014 Jul;81(1):109-16. doi: 10.1111/cen.12396. Epub 2014 Jan 21. Clin Endocrinol (Oxf). 2014. PMID: 24382015

2

Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.

Shi Y, Parhar RS, Zou M, Baitei E, Kessie G, Farid NR, Alzahrani A, Al-Mohanna FA. Shi Y, et al. Hum Gene Ther. 2003 Dec 10;14(18):1741-51. doi: 10.1089/104303403322611755. Hum Gene Ther. 2003. PMID: 14670125

3

High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.

Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Abu-Amero KK, et al. Among authors: alzahrani as. Oncogene. 2005 Feb 17;24(8):1455-60. doi: 10.1038/sj.onc.1208292. Oncogene. 2005. PMID: 15608681

4

Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.

Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Abu-Amero KK, et al. Among authors: alzahrani as. Oncogene. 2006 Feb 2;25(5):677-84. doi: 10.1038/sj.onc.1209094. Oncogene. 2006. PMID: 16205644

5

Clinical case seminar: metastatic follicular thyroid carcinoma arising from congenital goiter as a result of a novel splice donor site mutation in the thyroglobulin gene.

Alzahrani AS, Baitei EY, Zou M, Shi Y. Alzahrani AS, et al. J Clin Endocrinol Metab. 2006 Mar;91(3):740-6. doi: 10.1210/jc.2005-2302. Epub 2006 Jan 10. J Clin Endocrinol Metab. 2006. PMID: 16403815

6

Thiamine transporter mutation: an example of monogenic diabetes mellitus.

Alzahrani AS, Baitei E, Zou M, Shi Y. Alzahrani AS, et al. Eur J Endocrinol. 2006 Dec;155(6):787-92. doi: 10.1530/eje.1.02305. Eur J Endocrinol. 2006. PMID: 17132746

7

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA. Shi Y, et al. Among authors: alzahrani as. Cancer Gene Ther. 2008 Feb;15(2):101-7. doi: 10.1038/sj.cgt.7701101. Epub 2007 Dec 21. Cancer Gene Ther. 2008. PMID: 18197164

8

Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation.

Alzahrani AS, Al-Khaldi N, Shi Y, Al-Rijjal RA, Zou M, Baitei EY, Amin T. Alzahrani AS, et al. Endocr Pract. 2008 Jul-Aug;14(5):595-602. doi: 10.4158/EP.14.5.595. Endocr Pract. 2008. PMID: 18753104

9

Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Zou M, Baitei EY, Alzahrani AS, Al-Mohanna F, Farid NR, Meyer B, Shi Y. Zou M, et al. Among authors: alzahrani as. Neoplasia. 2009 Jan;11(1):57-65. doi: 10.1593/neo.81044. Neoplasia. 2009. PMID: 19107232 Free PMC article.

10

Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.

Baitei EY, Zou M, Al-Mohanna F, Collison K, Alzahrani AS, Farid NR, Meyer B, Shi Y. Baitei EY, et al. Among authors: alzahrani as. J Pathol. 2009 Apr;217(5):707-15. doi: 10.1002/path.2496. J Pathol. 2009. PMID: 19156774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters